Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-22

Clinical Trial Update: Safety Trial of Live Attenuated Influenza (H7N3) Vaccine [Phase 1]

View source ↗

Summary

Phase 1 safety trial of a live attenuated H7N3 influenza vaccine completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Live Attenuated H7N3 influenza vaccine

Snippet

Sponsor: PATH | Conditions: Influenza, Avian Influenza | Phase 1 | Status: COMPLETED | Results posted: 2019-04-22